American Journal on Addictions

Papers
(The H4-Index of American Journal on Addictions is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Brief Report: Increased Addictive Internet and Substance Use Behavior During the COVID‐19 Pandemic in China313
Internet Addiction Increases in the General Population During COVID‐19: Evidence From China94
Editorial: Challenges to Opioid Use Disorders During COVID‐1964
Microinduction of Buprenorphine/Naloxone: A Review of the Literature54
Method for Successfully Inducting Individuals Who Use Illicit Fentanyl Onto Buprenorphine/Naloxone52
Initial Information on a Novel Nicotine Product39
Increasing Heroin‐Methamphetamine (Goofball) Use and Related Morbidity Among Seattle Area People Who Inject Drugs36
Patients' perceptions of telehealth services for outpatient treatment of substance use disorders during the COVID‐19 pandemic33
The Increasing Prevalence of Fentanyl: A Urinalysis‐Based Study Among Individuals With Opioid Use Disorder in New York City24
Building Outreach and Diversity in the Field of Addictions21
Mobile, Community‐Based Buprenorphine Treatment for Veterans Experiencing Homelessness With Opioid Use Disorder: A Pilot, Feasibility Study21
Examining Associations Between Licensed and Unlicensed Outlet Density and Cannabis Outcomes From Preopening to Postopening of Recreational Cannabis Outlets20
Development and Feasibility Study of an Addiction‐Focused Phenotyping Assessment Battery18
Prevalence of problematic Internet use and its association with quality of life among undergraduate nursing students in the later stage of COVID‐19 pandemic era in China18
Review Article: Anabolic‐Androgenic Steroids, Violence, and Crime: Two Cases and Literature Review18
A Literature Review Examining Primary Outcomes of Medication Treatment Studies for Opioid Use Disorder: What Outcome Should Be Used to Measure Opioid Treatment Success?17
A Case Report: Rapid Micro‐Induction of Buprenorphine/Naloxone to Administer Buprenorphine Extended‐Release in an Adolescent With Severe Opioid Use Disorder17
0.095012903213501